´ëÇÑ°»³â±âÇÐȸ 2023 µ¿°è¿öÅ©¼¥ : 2023-02-11±³À°ÀÏÀÚ : 2023-02-11
±³À°Àå¼Ò : À¯¼ºÈ£ÅÚ 3Ãþ ŷȦ
±³À°ÁÖÁ¦ :
´ëÇÑ°»³â±âÇÐȸ 2023 µ¿°è¿öÅ©¼¥ÁÖÃÖ±â°ü : ´ëÇÑ°¡Á¤ÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°»³â±âÇÐȸ
´ã´çÀÚ : Ȳ¼º¿ø
¿¬¶ôó : 02-540-2206
À̸ÞÀÏ :
menopause2011@naver.com ±³À°Á¾·ù : °¡Á¤ÀÇÇаú±âŸ
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
´ëÀü±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-11 À¯¼ºÈ£ÅÚ 3Ãþ ŷȦ 15:00~15:45 Emerging game-changers? Semaglutide and Tirzepatide ¼¿øÀ±(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02-11 À¯¼ºÈ£ÅÚ 3Ãþ ŷȦ 16:00~16:45 AMH; How old are you, reproductively? ÀÌû¿ì(Áß¾Óº¸Èƺ´¿ø)
±³À°½Ã°£ 02-11 À¯¼ºÈ£ÅÚ 3Ãþ ŷȦ 16:45~17:30 M2BPGi, pros and cons ÇÑ°ÇÈñ(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 02-11 À¯¼ºÈ£ÅÚ 3Ãþ ŷȦ 17:30~18:15 How to prevent rebound-associated bone loss? ±è¿ëȯ(ÃæºÏÀÇ´ë)